Buy Pluristem Therapeutics Stock | PSTI Stock Price & Latest News | Public
PSTI

Pluristem Therapeutics

$0.00 (0.00%)Today
    Small Market Cap

    About PSTI

    Pluristem Therapeutics, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The firm focuses on the devel...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.15
    -0.31
    -0.46
    Q3 2019
    Q4 2019
    Q1 2020
    Q2 2020

    Expected EPS
    Q2 2020

    -$0.40

    Actual EPS
    Q2 2020

    -$0.32

    Stats

    Market Cap$284,67M
    Volume7,83k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$13.29
    1 Year Low$2.82
    Open$10.99
    High$11.03
    Low$10.45

    Buy any stock with any amount of money.

    Download the App
    Download the app